Gainers
- Clearside Biomedical Inc (NASDAQ:CLSD) surged 45.2 percent to $11.35 after the clinical biopharmaceutical company announced an encouraging update from ongoing clinical studies. The company said its pivotal phase 3 clinical trial of its suprachoroidal CLS-TA in patients with macular edema achieved positive topline results.
- Innovate Biopharmaceuticals Inc (NASDAQ:INNT) shares surged 40.9 percent to $13.36 after climbing 54.15 percent on Friday.
- XL Group Ltd. (NYSE:XL) shares gained 29.3 percent to $55.99 after the insurance company agreed to sell itself to France's AXA for $15 billion, or $57.60 per share.
- Carver Bancorp Inc (NASDAQ:CARV) shares rose 26.1 percent to $3.62.
- Vericel Corp (NASDAQ:VCEL) shares climbed 25.2 percent to $10.45 following better-than-expected Q4 earnings.
- GTx, Inc. (NASDAQ:GTXI) rose 21.5 percent to $20.43 as the company issued Phase 2 data for enobosarm for urinary incontinence.
- iPic Entertainment Inc (NASDAQ:IPIC) surged 18.2 percent to $13.38. Roth Capital initiated coverage on iPic Entertainment with a Buy rating and a $18.00 price target.
- ITUS Corp (NASDAQ:ITUS) shares gained 10.8 percent to $3.61 after the company reported a partnership with Serametrix for ITUS' Cchek.
- Intrepid Potash, Inc. (NYSE:IPI) climbed 10.7 percent to $3.94. Cowen & Co. upgraded Intrepid Potash from Underperform to Market Perform.
- Dragon Victory International Limited (NYSE:LYL) shares rose 10.2 percent to $3.78.
- Tenax Therapeutics Inc (NASDAQ:TENX) gained 10 percent to $8.47 after dropping 27.36 percent on Friday.
- Casa Systems Inc (NASDAQ:CASA) shares gained 9.1 percent to $23.94.
- Tyme Technologies Inc (NASDAQ:TYME) climbed 7.9 percent to $2.47.
- Alliance One International, Inc. (NYSE:AOI) shares rose 7.2 percent to $23.20
- Aimmune Therapeutics Inc (NASDAQ:AIMT) shares gained 6.8 percent to $36.39 after the company presented results from its pivotal Phase 3 PALISADE trial of AR101 for peanut allergy at the AAAAI-WAO.
- ACM Research Inc (NASDAQ:ACMR) gained 6.4 percent to $7.70 after the company reported upbeat Q4 results.
- MacroGenics Inc (NASDAQ:MGNX) climbed 6.3 percent to $30.75. H.C. Wainwright initiated coverage on MacroGenics with a Buy rating.
- Groupon Inc (NASDAQ:GRPN) rose 5 percent to $4.48. Morgan Stanley upgraded Groupon from Underweight to Equal-Weight.
- Corindus Vascular Robotics Inc (NYSE:CVRS) gained 4 percent to $1.09. The developer of precision vascular robotics announced it has received a 510(k) clearance from the U.S. Food and Drug Administration for its automated robotic movement designed for the CorPath GRX platform.
Check out these big penny stock gainers and losers
Losers
- Dermira Inc (NASDAQ:DERM) shares tumbled 63.2 percent to $9.27 as the company disclosed that its two Phase 3 trials evaluating olumacostat glasaretil in patients with acne vulgaris did not meet co-primary endpoints.
- Sparton Corporation (NYSE:SPA) declined 24.3 percent to $17.28 after the company reported termination of merger agreement with Ultra.
- Smith Micro Software, Inc. (NASDAQ:SMSI) fell 23.4 percent to $1.65 as the company announced a $5 million private placement.
- BRF SA (ADR) (NYSE:BRFS) shares dropped 14.5 percent to $8.05.
- Babcock & Wilcox Enterprises Inc (NYSE:BW) fell 11.8 percent to $4.87. Wynnefield Capital disclosed that it will fully subscribe to Babcok & Wilcox's rights offering.
- Nextdecade Corp (NASDAQ:NEXT) shares dropped 11.1 percent to $5.61.
- USA Truck, Inc. (NASDAQ:USAK) fell 11 percent to $22.88.
- Vectrus Inc (NYSE:VEC) slipped 8 percent to $34.00. Drexel Hamilton downgraded Vectrus from Buy to Hold.
- United Bancshares Inc. OH (NASDAQ:UBOH) shares declined 7.3 percent to $20.40.
BWBabcock & Wilcox Enterprises Inc
$5.43-1.81%
CARVCarver Bancorp Inc
$1.43-14.9%
DERMJourney Medical Corp
$7.841.88%
GRPNGroupon Inc
$15.871.93%
IPIIntrepid Potash Inc
$26.640.15%
IPICIPic Entertainment Inc
$0.00010-%
MGNXMacrogenics Inc
$1.35-0.36%
NEXTNextDecade Corp
$5.04-1.66%
SMSISmith Micro Software Inc
$0.6000-1.01%
TENXTenax Therapeutics Inc
$10.821.98%
UBOHUnited Bancshares Inc
$38.3195.0%
VCELVericel Corp
$36.380.49%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
